Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2013
12/12/2013US20130330772 Anti-erbb3 antibodies
12/12/2013US20130330770 Methods for modulating mannose content of recombinant proteins
12/12/2013US20130330769 Serpin Fusion Polypeptides And Methods Of Purification Thereof
12/12/2013US20130330768 Methods for culturing human myeloid leukaemia cells and cells derived therefrom
12/12/2013US20130330744 Nitrated cardiac troponin i as a biomarker of cardiac ischemia
12/12/2013US20130330742 Assay for colon and other cancers in humans
12/12/2013US20130330719 Eml4-alk translocations in lung cancer
12/12/2013US20130330362 Humanized anti-egfr antibody l4-h3 and coding gene thereof
12/12/2013US20130330360 Antagonistic dr3 ligands
12/12/2013US20130330357 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330356 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
12/12/2013US20130330355 Anti-il-1beta antibodies and methods of use
12/12/2013US20130330352 Treatment of myocardial infarction using tgf beta antagonists
12/12/2013US20130330351 Antibody and methods for selective inhibition of t-cell responses
12/12/2013US20130330350 Antibody Scaffold For Homogenous Conjugation
12/12/2013US20130330349 High affinity molecules capable of binding a type a plexin receptor and uses of same
12/12/2013US20130330348 Anti-ngf antibodies and their use
12/12/2013US20130330347 Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
12/12/2013US20130330346 Chemokine receptor binding polypeptides
12/12/2013US20130330345 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii
12/12/2013US20130330343 Composition and method for the diagnosis and treatment of iron-related disorders
12/12/2013US20130330342 Antibody fragments inhibiting hiv nef protein
12/12/2013US20130330340 Production of n- and o-sialylated tnfrii-fc fusion protein in yeast
12/12/2013US20130330337 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/12/2013US20130330336 Fibroblast growth factor 21 proteins
12/12/2013US20130330335 Bioinformatic processes for determination of peptide binding
12/12/2013US20130330333 Treatment of angiogenesis disorders
12/12/2013US20130330332 Treatment of pemphigus
12/12/2013US20130330331 Method of Treating Degenerative Disorders of the Nervous System
12/12/2013US20130330330 Anti-il-tif antibodies
12/12/2013US20130330329 B7-h7 antibodies and method of use
12/12/2013US20130330323 Rapid Generation of Anti-Idiotypic Antibodies
12/12/2013US20130330275 Misfolded proteins in cancer treatment and diagnosis
12/12/2013CA2875989A1 Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
12/12/2013CA2875783A1 Caninized anti-ngf antibodies and methods thereof
12/12/2013CA2875703A1 Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof
12/12/2013CA2875451A1 Antibody against transporter and use thereof
12/12/2013CA2874846A1 Methods for making fully human bispecific antibodies using a common light chain
12/11/2013EP2671976A1 Antibody preparation method, and antibody and antibody library thus prepared
12/11/2013EP2671891A2 Ang-2 inhibition to treat multiple sclerosis
12/11/2013EP2670840A2 Methods and devices for immunodiagnostic applications
12/11/2013EP2670779A1 Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
12/11/2013EP2670778A1 Novel antigen binding proteins
12/11/2013EP2670777A1 A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human c44-fragment of agrin
12/11/2013EP2670776A1 Fc VARIANTS AND METHODS FOR THEIR PRODUCTION
12/11/2013EP2670775A1 Anti-tace antibody molecules and their uses
12/11/2013EP2670440A1 Human antibodies and antibody-drug conjugates against cd74
12/11/2013EP2670436A2 Foxc1 antibodies and methods of their use
12/11/2013EP2650309A9 Conjugate of folate and antibody, preparation method and use thereof
12/11/2013EP2083858B1 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators
12/11/2013CN103443285A Antibodies that specifically bind staphylococcus aureus [alpha] toxin and methods of use
12/11/2013CN103443127A Human tissue factor antibody and uses thereof
12/11/2013CN103443126A Ligands that bind TGF-beta receptor II
12/11/2013CN103443125A Low affinity blood brain barrier receptor antibodies and uses therefor
12/11/2013CN103443124A Il-21 ligands
12/11/2013CN103442729A Treatment and prevention of malaria
12/11/2013CN103436583A Method for producing therapeutic monoclonal antibody of canine distemper virus, product thereof and hybridoma cell
12/11/2013CN103436574A Use of human cells of myeloid leukaemia origin for expression of antibodies
12/11/2013CN103436496A Anti-mycoplasma bovis monoclonal antibody, hybridoma cell strain secreting monoclonal antibody and application
12/11/2013CN103436495A Hybridoma cell strain, anti-rat-human beta-tubulin-3 monoclonal antibody, and immunohistochemical kit and application of anti-rat-human beta-tubulin-3 monoclonal antibody
12/11/2013CN103435698A Sclerostin结合剂 Sclerostin binding agents
12/11/2013CN103435697A Neutralizing antibodies to influenza viruses
12/11/2013CN103435696A Methods of modifying antibodies, and modified antibodies with improved functional properties
12/11/2013CN103435695A Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
12/11/2013CN103435685A Monoclonal antibody capable of resisting fibrinogen-like protein, and application thereof
12/11/2013CN103435683A SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same
12/11/2013CN103060274B RANKL-TNF sample region mouse monoclonal antibody and its preparation method and use
12/11/2013CN102863533B Method for humanized reform for antibody
12/11/2013CN102731653B Anti-phosphorylation Oct4 protein antibody and its application
12/11/2013CN102702354B Monoclonal antibody against human neurofilament medium molecular weight subunit and preparation method and application thereof
12/11/2013CN102627628B Chlorantraniliprole antigen, its preparation method and application
12/11/2013CN102558349B Monoclonal antibody capable of recognizing natural-structure sika prion and preparation method
12/11/2013CN102268408B Hybridoma cell strain able to secrete anti-beta-lactamase monoclonal antibody and preparation method thereof
12/11/2013CN102056591B Liposome medicament and preparation method and use thereof
12/11/2013CN101968481B Method for detecting existence of heavy metal copper ion in sample and special kit thereof
12/10/2013US8604174 High affinity fully human monoclonal antibodies to interleukin-8
12/10/2013US8604173 Dopaminergic neuron progenitor cell marker 187A5
12/10/2013US8604171 High affinity, anti-human IgE antibodies
12/10/2013US8604170 Antibody against the CSF-1R
12/10/2013US8604169 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
12/10/2013US8604161 Prion protein ligands and methods of use
12/10/2013US8603987 Monoclonal antibodies to fibroblast growth factor receptor 2
12/10/2013US8603794 Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same
12/10/2013US8603793 Polypeptides having cellobiohydrolase 1 activity and polynucleotides encoding same
12/10/2013US8603778 Anti-TNF antibodies, compositions, methods and uses
12/10/2013US8603765 Immunoassay reagents and methods of use thereof
12/10/2013US8603759 Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
12/10/2013US8603483 Anti-integrin immunoconjugates, methods and uses
12/10/2013US8603481 Therapeutic agents for solid tumors
12/10/2013US8603474 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
12/10/2013US8603473 Modified binding molecules comprising connecting peptides
12/10/2013US8603471 Methods and compositions for preventing the onset of type 1 diabetes
12/10/2013US8603470 Use of IL-20 antagonists for treating liver diseases
12/10/2013US8603469 Methods of treating cancer with human monoclonal antibodies against interleukin 8
12/10/2013CA2580141C Cysteine engineered antibodies and conjugates
12/10/2013CA2576925C Method of delivering rna interference and uses thereof
12/10/2013CA2541535C Antibodies to nik, their preparation and use
12/10/2013CA2502367C Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
12/10/2013CA2465314C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
12/10/2013CA2465040C An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 1494